Sven Karlsson

Sven Karlsson is a biotech and life sciences entrepreneur, executive, and advisor known for his innovative solutions to address high unmet needs in patient populations.

With a background in Operations Research from Cornell University and an MBA with Distinction in Finance from NYU Stern School of Business, Sven has a strong educational foundation.

Sven Karlsson co-founded and served as the Chief Operating Officer of PlateletBio, a prominent cell therapy platform that focused on leveraging platelet biology. Under his leadership, the company secured over $100 million in funding and grew a team of over 50 dedicated professionals.

His extensive experience in both operating and venture capital roles gives him a unique perspective on emerging technologies and the challenges of business scaling and operations.

Sven has had diverse roles in various organizations like Osmo, Bioviida Venture Studio, JScreen, Syenex, UCSF Innovation Ventures, Clean Energy Venture Group, NextGen Venture Partners, and many more.

He has also contributed as an advisor, board member, or observer in companies specializing in biotechnology, energy efficiency, clean energy, and technology, showcasing his broad expertise and interests.